Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 2/20 | 0.47 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.39 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.39 |
| ▸ | CTPS1 | P17812 | 1/20 | 0.38 |
| ▸ | CKS1B | P61024 | 1/20 | 0.38 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.38 |
| ▸ | CCR6 | P51684 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CCR9 | P51686 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12415565 | 1.00 | CYP11B1 (0.47) | CYP11B1CYP11B2CYP3A4CACNA1BNR1I2 | |
| Trifluoroacetic Acid SCHEMBL2192773 | 0.95 | CYP11B1 (0.43) | CYP11B1CYP11B2CYP3A4CACNA1BNR1I2 | |
| Trifluoroacetic Acid SCHEMBL2187768 | 0.95 | CYP11B1 (0.43) | CYP11B1CYP11B2CYP3A4CACNA1BNR1I2 | |
| SCHEMBL12415571 | 0.91 | CYP3A4 (0.43) | CYP11B1CYP11B2CYP3A4CACNA1BNR1I2 | |
| SCHEMBL12415578 | 0.91 | CYP3A4 (0.43) | CYP11B1CYP11B2CYP3A4CACNA1BNR1I2 | |
| SCHEMBL2188667 | 0.91 | CYP3A4 (0.45) | CYP11B1CYP11B2CYP3A4CACNA1BNR1I2 | |
| SCHEMBL2188926 | 0.91 | CYP3A4 (0.45) | CYP11B1CYP11B2CYP3A4CACNA1BNR1I2 | |
| Trifluoroacetic Acid SCHEMBL2194144 | 0.87 | CACNA1B (0.44) | CYP11B1CYP11B2CYP3A4CACNA1BNR1I2 | |
| Trifluoroacetic Acid SCHEMBL2190207 | 0.87 | CACNA1B (0.44) | CYP11B1CYP11B2CYP3A4CACNA1BNR1I2 | |
| SCHEMBL2190018 | 0.86 | CACNA1B (0.49) | CYP3A4CACNA1BNR1I2TSHRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110172236-A1 | SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | CHAKRAVARTY PRASUN K | 2011-07-14 | — | — | US | disclosed |
| US-20110172236-A1 | SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | CHAKRAVARTY PRASUN K | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172236-A1 | SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | TRPV1, TRPA1, CACNA1D | CYP11B1 922/4885CYP11B2 985/4885CYP3A4 939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.